Company Filing History:
Years Active: 2002-2003
Title: Innovations by Laura Penny: Pioneering Drug Metabolism Research in San Diego
Introduction
Laura Penny, an accomplished inventor based in San Diego, CA, has made significant strides in the field of genetic research. With a total of two patents to her name, her work primarily focuses on understanding drug metabolism through genetic polymorphisms.
Latest Patents
Her most recent patents include "Genotyping the human UDP-glucuronosyltransferase 2B7 (UGT2B7) gene" and "Genotyping the human UDP-glucuronosyltransferase 1 (UGT1) gene." Both patents involve the identification of genetic polymorphisms that influence the metabolizing capabilities of the UGT2B and UGT1 genes. These nucleic acids are pivotal for screening patients regarding altered metabolism, potential drug-drug interactions, adverse effects, and diseases linked to environmental or occupational toxins. Furthermore, these inventions aid in establishing animal, cell, and in vitro models for comprehensive drug metabolism studies.
Career Highlights
Laura Penny is currently affiliated with Dna Sciences Laboratories, Inc., where her innovative research contributes to advancements in pharmacogenomics. Her focus on genetic variants demonstrates her commitment to improving patient care and drug safety.
Collaborations
Throughout her career, Laura has collaborated with notable colleagues such as Margaret Galvin and Andrew Miller. These partnerships enhance the research capabilities at Dna Sciences Laboratories, Inc., fostering a collaborative environment that encourages groundbreaking discoveries in genetic research.
Conclusion
Laura Penny's contributions to the field of drug metabolism through her patented innovations reflect her dedication to enhancing medical science. As her research progresses, it holds the potential to revolutionize how personalized medicine is approached, ensuring better health outcomes for patients.